Company / Accounts Receivable
CANNAPHARMARX, INC. Accounts Receivable History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$164.4K
FY2025
5-year range
$1.7K / $164.4K
FY2024-FY2025
Trend
+9312.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$164,430 in FY2025.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, accounts receivable increased 9312.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -18.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $164.4K | +9312.1% |
| FY2024 | $1.7K | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026